Theravance Biopharma (TBPH) Earnings Date & Reports

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

TBPH is expected to report earnings to fall 20.52% to -21 cents per share on August 11

Theravance Biopharma TBPH Stock Earnings Reports

Q2'25

Est.

$-0.21

Q1'25

Missed

by $0.05

Q4'24

Missed

by $0.11

Q3'24

Missed

by $0.03

Q2'24

Missed

by $0.13

The last earnings report on May 08 showed earnings per share of -27 cents, missing the estimate of -21 cents. With 365.64K shares outstanding, the current market capitalization sits at 445.51M.

View a ticker or compare two or three

Compare

TBPH